Thursday, 1 December 2022

Alembic Pharma receives USFDA Approval for Diclofenac Sodium Topical Solution

Alembic Pharma receives USFDA Approval for Diclofenac Sodium Topical Solution
Alembic Pharma receives USFDA Approval for Diclofenac Sodium Topical Solution
Pradip Mahajan Thu, 12/01/2022 - 15:36

Alembic Pharmaceuticals Limited, a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907. Headquartered in India, Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world.



source https://www.pharmatutor.org/pharma-news/2022/alembic-pharma-receives-usfda-approval-for-diclofenac-sodium-topical-solution

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...